Further analysis comparing the expression of PD-L1 in NSCLC tumors with p53 mutations (n = 84) and p53 wild-type tumors (n = 97) showed that the latter had significantly higher levels of PD-L1 compared to the former (P = 0.03). Here, TP53 is linked to non-small cell lung carcinoma.